Nachum Kaplan
Corporate Officer/Principal en Tel-Aviv University .
Perfil
Nachum Kaplan currently works at Tel-Aviv University, as Member from 1989.
Dr. Kaplan also formerly worked at Affinium Pharmaceuticals Ltd., as Vice President-Microbiology from 2002 to 2013.
Dr. Kaplan received his doctorate degree from Tel-Aviv University.
Cargos activos de Nachum Kaplan
| Empresas | Cargo | Inicio |
|---|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | 21/04/2010 |
Antiguos cargos conocidos de Nachum Kaplan.
| Empresas | Cargo | Fin |
|---|---|---|
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Director Técnico/Científico/I+D | - |
Formación de Nachum Kaplan.
| Tel-Aviv University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Nachum Kaplan